Authors:
Harland, M
Mistry, S
Bishop, DT
Bishop, JAN
Citation: M. Harland et al., A deep intronic mutation in CDKN2A is associated with disease in a subset of melanoma pedigrees, HUM MOL GEN, 10(23), 2001, pp. 2679-2686
Authors:
Wachsmuth, RC
Gaut, RM
Barrett, JH
Saunders, CL
Randerson-Moor, JA
Eldridge, A
Martin, NG
Bishop, T
Bishop, JAN
Citation: Rc. Wachsmuth et al., Heritability and gene-environment interactions for melanocytic nevus density examined in a UK adolescent twin study, J INVES DER, 117(2), 2001, pp. 348-352
Authors:
Bishop, JAN
Wachsmuth, RC
Harland, M
Bataille, V
Pinney, E
Mack, P
Baglietto, L
Cuzick, J
Bishop, DT
Citation: Jan. Bishop et al., Genotype/phenotype and penetrance studies in melanoma families with germline CDKN2A mutations, J INVES DER, 114(1), 2000, pp. 28-33
Authors:
Bishop, JAN
Bradburn, M
Bergman, W
Osterlind, A
Pinney, E
Rosdahl, I
Scerri, L
Weichenthal, M
Mant, D
Breitbart, EW
Karlsson, P
Altman, DG
Citation: Jan. Bishop et al., Teaching non-specialist health care professionals how to identify the atypical mole syndrome phenotype: a multinational study, BR J DERM, 142(2), 2000, pp. 331-337
Authors:
Kupsch, JM
Tidman, NH
Kang, NV
Truman, H
Hamilton, S
Patel, N
Bishop, JAN
Leigh, IM
Crowe, JS
Citation: Jm. Kupsch et al., Isolation of human tumor-specific antibodies by selection of an antibody phage library on melanoma cells, CLIN CANC R, 5(4), 1999, pp. 925-931
Authors:
Kefford, RF
Bishop, JAN
Bergman, W
Tucker, MA
Citation: Rf. Kefford et al., Counseling and DNA testing for individuals perceived to be genetically predisposed to melanoma: A consensus statement of the melanoma genetics consortium, J CL ONCOL, 17(10), 1999, pp. 3245-3251